MedPath

eTMS for Veterans and First Responders With PTSD

Not Applicable
Recruiting
Conditions
Post Traumatic Stress Disorder
Interventions
Device: Electroencephalogram personalized Transcranial Magnetic Stimulation (eTMS)
Registration Number
NCT06294106
Lead Sponsor
Virginia Polytechnic Institute and State University
Brief Summary

A battery of physiological and behavioral data will be collected before and after application of eTMS. Participants will be veterans or first responders diagnosed with PTSD. Study will be a double-blind, sham-controlled, parallel group, randomized clinical trial.

Detailed Description

Veterans and first responders diagnosed with PTSD will be studied to evaluate safety and efficacy of an EEG personalized TMS paradigm. All participants will undergo 2 days of extensive testing prior to eTMS application and 2 days of testing after. Testing will include MRI, OPM, EEG, behavioral tasks, questionnaires, and an EEG sleep study.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Veteran or first responder
  • diagnosed with post-traumatic stress disorder with PCL-5 cutoff of 31 or above
Read More
Exclusion Criteria
  • Claustrophobia
  • Contraindications to MRI
  • Pregnant
  • Uncontrolled medical, psychological, or neurological conditions
  • Unable to calculate EEG alpha frequency
  • History of ECT or rTMS
  • History of intracranial lesion or increased intracranial pressure
  • History of stroke
  • History of other neurologic conditions
  • Family history of epilepsy
  • Personal history of epilepsy
  • certain medications
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
eTMSElectroencephalogram personalized Transcranial Magnetic Stimulation (eTMS)The active side of a TMS coil will be used to administer eTMS application.
eTMS shamElectroencephalogram personalized Transcranial Magnetic Stimulation (eTMS)The sham side of a TMS coil will be used to administer a sham dosage of eTMS application.
Primary Outcome Measures
NameTimeMethod
Adverse EventsUp to 7 weeks

Adverse event reports (or lack-of) will determine device safety

Report of SymptomsUp to 7 weeks

Symptom questionnaire to be completed before and after all study procedures to determine feasibility in this patient population. Various symptoms will be rated on a likert scale from absent to severe.

Secondary Outcome Measures
NameTimeMethod
PCL-5Up to 7 weeks

Completion of the PTSD symptom questionnaire. Scores range from 0-80, with a PTSD cutoff score of 31.

OPM1 session 1 week pre treatment and 1 session 1 week post treatment

Optically Pumped Magnetometry signals collected at rest and during basic tasks to assess neuropathways of activation

EEGUp to 7 sessions collected over 7 weeks.

Electroencephalography recordings at rest and during a stress task. Specifically analyzing the P300.

fMRI1 session 1 week pre treatment and 1 session 1 week post treatment

Functional MRI signals including BOLD signals collected at rest and during basic tasks to assess neuropathways of activation

Trial Locations

Locations (1)

Fralin Biomedical Research Institute

🇺🇸

Roanoke, Virginia, United States

© Copyright 2025. All Rights Reserved by MedPath